Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2020. Start Trial.
Date Value
October 23, 2026 1.090
October 22, 2026 1.110
October 21, 2026 1.130
October 20, 2026 1.128
October 19, 2026 1.104
October 16, 2026 1.085
October 15, 2026 1.116
October 14, 2026 1.097
October 13, 2026 1.101
October 12, 2026 1.186
October 09, 2026 1.200
October 08, 2026 1.139
October 07, 2026 1.179
October 06, 2026 1.184
October 05, 2026 1.208
October 02, 2026 1.199
October 01, 2026 1.198
September 30, 2026 1.216
September 29, 2026 1.220
September 28, 2026 1.226
September 25, 2026 1.219
September 24, 2026 1.228
September 23, 2026 1.218
September 22, 2026 1.248
September 21, 2026 1.213
Date Value
September 18, 2026 1.189
September 17, 2026 1.221
September 16, 2026 1.186
September 15, 2026 1.196
September 14, 2026 1.223
September 11, 2026 1.197
September 10, 2026 1.193
September 09, 2026 1.214
September 08, 2026 1.221
September 04, 2026 1.284
September 03, 2026 1.273
September 02, 2026 1.284
September 01, 2026 1.261
August 31, 2026 1.257
August 28, 2026 1.263
August 27, 2026 1.378
August 26, 2026 1.393
August 25, 2026 1.411
August 24, 2026 1.396
August 21, 2026 1.442
August 20, 2026 1.372
August 19, 2026 1.400
August 18, 2026 1.148
August 17, 2026 1.133
August 14, 2026 1.152

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc --
Moderna, Inc. 11.81
Mereo BioPharma Group Plc 1.569
NuCana Plc 26.28
Immatics NV 2.187

Price to Book Value Related Metrics

PS Ratio 7.051
PEG Ratio -0.0288
Price to Free Cash Flow 51.38
Price 88.12
Earnings Yield -8.91%
Market Cap 22.13B
PEGY Ratio -0.0288